HA

Healthcare · Pharmaceuticals

Haleos Labs Limited (HALEOSLABS)

₹1,600.00

Mkt cap
₹487 Cr
P/E ratio
37.60
P/B
2.21
Div yield
0.09%
ROE
8.44%
ROCE
9.94%
EPS (TTM)
₹42.55
Book value
₹725
52W range
1,091–1,774
Sector
Healthcare

Price history

Previous close

Incorporated in 2006, SMS Lifesciences Ltd is in the business of manufacturing of Active Pharma Ingredients and their intermediates [1]

NSE HALEOSLABSBSE 540679
Health check
Cautious
ValuationFair
ProfitabilityWeak
GrowthLow
TechnicalsBullish
52-week range
−9.81% from high
₹1,600
₹1,091+46.64% from low₹1,774
Current
₹1,600.00
Prev close
₹1,580.50
Day
+1.23%
Price performance
1D
+1.23%
1W
+0.60%
1M
−0.70%
3M
+9.86%
6M
−0.54%
1Y
+29.29%
YTD
+18.17%

Financials

Revenue, profit & margin
P/E ratio
37.6×
HALEOSLABS is 16% above the sector median of 32.5×
HALEOSLABS37.6×
Sector median32.5×
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales69.2672.0589.9992.5578.4684.6089.1182.5081.3794.7875.1472.9491.38
YoY Sales growth-14.77%-18.39%+41.21%+23.98%+13.28%+17.42%-0.98%-10.86%+3.71%+12.03%-15.68%-11.59%+12.30%
Expenses61.3362.7578.6376.2769.8971.8581.6970.7967.7980.7370.9863.8283.06
Operating Profit7.939.3011.3616.288.5712.757.4211.7113.5814.054.169.128.32
OPM %11.45%12.91%12.62%17.59%10.92%15.07%8.33%14.19%16.69%14.82%5.54%12.50%9.10%
Other Income0.270.582.360.442.040.062.341.000.420.182.010.460.08
Interest2.812.342.842.402.142.142.031.871.621.541.421.902.15
Depreciation3.733.733.783.683.763.763.803.823.893.913.854.244.25
Profit before tax1.663.817.1010.644.716.913.937.028.498.780.903.442.00
Tax %126.51%-8.14%8.73%33.27%29.72%29.81%11.45%37.61%24.38%24.26%62.22%46.51%12.50%
Net Profit-0.444.126.477.103.304.863.484.396.426.650.351.841.76
EPS in Rs2.2514.2219.5223.1515.4518.099.8213.7620.1821.901.468.7710.78
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move −3.76% · closed higher next day 1 of last 2
 Q1FY27Q2FY27
Broadcast5 Aug '2611 Nov '26
Earnings day−7.27%−0.25%
+1 day−6.55%+13.68%
+5 days−5.73%+16.41%
+15 days−2.51%—
+30 days−3.03%—
FilingXBRLXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
72.10%Promoter
Promoters72.10%
FIIs0.00%
DIIs0.31%
Public27.58%
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,884.9036.764,52,2510.85%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,180.5086.862,96,8070.27%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,689.5082.161,78,3740.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,294.6092.531,23,9800.09%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,200.0026.421,19,7000.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,390.2041.471,16,1190.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,415.0036.811,14,3160.92%852−35.05%7,404−2.44%15.49%
Haleos Labs Limited₹1,610.8037.554870.09%2−46.56%91+12.30%9.94%
Median: 160 Co.₹432.2032.471,9830.08%13+33.73%179+21.23%14.94%

Filings